top of page
< Back
17 January 2024

Horizon Capital invests in Viseven Group

Other News
7 July 2026
June 2026 Investment Digest
5 July 2026
Ukraine Tech Night Paris 2026 Recap
13 March 2025
Meet the UVCA 2025 Supervisory Board
23 June 2026
UADEVC 2026 Recap
4 June 2026
May 2026 Investment Digest

Congratulations to our member Horizon Capital with an investment in Viseven Group, one of the world's leading marketing technology companies.


Viseven serves more than 50 clients in the pharmaceutical and life sciences industries, as well as clients from 20 of the world's leading companies, including Abbott, AbbVie, Amgen, Bayer, Biogen, Ipsen, Lilly, Novo Nordisk, Servier Laboratories and others. The company demonstrates high performance, profitability, and a stable level of growth, as evidenced by the more than threefold increase in revenues since 2019.


More details can be found at this link. Our best wishes for success to the teams!



Share:
bottom of page